Madison, WI, United States of America

Gaoxiang Ge

This inventor holds 1 USPTO granted patent. Top assignee: Wisconsin Alumni Research Foundation. Active years: 2011.


Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 5(Granted Patents)


Company Filing History:


Years Active: 2011

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Gaoxiang Ge: Innovator in Fibrotic Disorder Treatment

Introduction

Gaoxiang Ge is a notable inventor based in Madison, WI (US). He has made significant contributions to the field of medical research, particularly in the treatment of fibrotic disorders. His innovative work has the potential to impact many lives by providing new therapeutic options.

Latest Patents

Gaoxiang Ge holds a patent for a composition aimed at treating fibrotic disorders. The patent, titled "Composition for treating a fibrotic disorder comprising an inhibitor of a BMP-1-like protein," focuses on the use of α-macroglobulin-related agents. These agents are designed to treat or prevent fibrotic disorders associated with fibrillogenesis. The patent also outlines methods for using these agents and producing them for therapeutic applications.

Career Highlights

Gaoxiang Ge is affiliated with the Wisconsin Alumni Research Foundation, where he continues to advance his research and innovation. His work is characterized by a commitment to developing effective treatments for complex medical conditions.

Collaborations

He has collaborated with esteemed colleagues, including Daniel S. Greenspan and Yue Zhang, to further enhance the impact of his research. Their combined expertise contributes to the development of innovative solutions in the medical field.

Conclusion

Gaoxiang Ge's contributions to the treatment of fibrotic disorders exemplify the importance of innovation in medicine. His work not only highlights his dedication to research but also offers hope for improved therapeutic options for patients.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…